相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
Sebahattin Cirak et al.
LANCET (2011)
P300/CBP-associated factor regulates Y-box binding protein-1 expression and promotes cancer cell growth, cancer invasion and drug resistance
Masaki Shiota et al.
CANCER SCIENCE (2010)
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
Charles J. David et al.
GENES & DEVELOPMENT (2010)
A Cell-permeable Stat3 SH2 Domain Mimetic Inhibits Stat3 Activation and Induces Antitumor Cell Effects in Vitro
Wei Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Overexpression of LEDGF/DFS70 Induces IL-6 via p38 Activation in HaCaT Cells, Similar to that Seen in the Psoriatic Condition
Takuya Takeichi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Enhanced Expression of PCAF Endows Apoptosis Resistance in Cisplatin-Resistant Cells
Gen Hirano et al.
MOLECULAR CANCER RESEARCH (2010)
BAMLET Activates a Lysosomal Cell Death Program in Cancer Cells
Paul Rammer et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Expansion of the eukaryotic proteome by alternative splicing
Timothy W. Nilsen et al.
NATURE (2010)
Anti-tumor activity of splice-switching oligonucleotides
John A. Bauman et al.
NUCLEIC ACIDS RESEARCH (2010)
Peptide-Morpholino Conjugate: A Promising Therapeutic for Duchenne Muscular Dystrophy
Hong M. Moulton et al.
OLIGONUCLEOTIDE THERAPEUTICS (2009)
Targeting STAT3 in cancer: how successful are we?
Pedbin Yue et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Combination of circulating CXCR4 and Bmi-1 mRNA in plasma: A potential novel tumor marker for gastric cancer
Wenrong Xu et al.
MOLECULAR MEDICINE REPORTS (2009)
Therapeutic Potential of Splice-Switching Oligonucleotides
John Bauman et al.
OLIGONUCLEOTIDES (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Vivo-Morpholinos: A non-peptide transporter delivers Morpholinos into a wide array of mouse tissues
Paul A. Morcos et al.
BIOTECHNIQUES (2008)
Of alphas and betas: distinct and overlapping functions of STAT3 isoforms
Sarah Dewilde et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Stat3 isoforms, α and β, demonstrate distinct intracellular dynamics with prolonged nuclear retention of stat3β mapping to its unique C-terminal end
Ying Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation
Z. Nagy et al.
ONCOGENE (2007)
Pyridone 6, a pan-janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells
Laura Pedranzini et al.
CANCER RESEARCH (2006)
Persistent activation of Stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells
T Gritsko et al.
CLINICAL CANCER RESEARCH (2006)
New and old functions of STAT3 - A pivotal target for individualized treatment of cancer
G Inghirami et al.
CELL CYCLE (2005)
PEX1 mutations in the Zellweger spectrum of the peroxisome biogenesis disorders
DI Crane et al.
HUMAN MUTATION (2005)
Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer
EB Haura et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice
XY Ling et al.
CANCER RESEARCH (2005)
A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells
H Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The STAT3 isoforms and have unique and specific functions
D Maritano et al.
NATURE IMMUNOLOGY (2004)
Differential roles of STAT1α at and STAT1β in fludarabine-induced cell cycle arrest and apoptosis in human B cells
F Baran-Marszak et al.
BLOOD (2004)
Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy
KS Selander et al.
CANCER RESEARCH (2004)
Transcription factors as targets for cancer therapy
JE Darnell
NATURE REVIEWS CANCER (2002)
Listening to silence and understanding nonsense: Exonic mutations that affect splicing
L Cartegni et al.
NATURE REVIEWS GENETICS (2002)
Specific ablation of Stat3β distorts the pattern of Stat3-responsive gene expression and impairs recovery from endotoxic shock
JY Yoo et al.
CELL (2002)
Identification and characterization of cis elements in the STAT3 gene regulating STAT3α and STAT3β messenger RNA splicing
H Shao et al.
BLOOD (2001)
分享论文
